The ultra-low temperature demands of the Pfizer (PFE) and BioNTech (BNTX) vaccine are paving a new path for vaccine delivery and storage.
While mRNA vaccines requires a smaller footprint for production than traditional vaccines, once they leave the production plant, there’s a whole new set of hurdles prompting logistics companies to adapt.
Planes have been retrofitted, GPS tracking has been authorized by the FAA, and states are buying large-volume freezers to meet the first generation of…
Source link
